750 PRECLINICAL PHARMACOKINETIC PROFILE OF IDX320, A NOVEL AND POTENT HCV PROTEASE INHIBITORS.S. Good,X.-R. Pan-Zhou,M. Larsson,S. Luo,J.R. Selden,H. Rashidzadeh,S. Bhadresa,M. Camire,C. Parsy,D. SurlerauxJOURNAL OF HEPATOLOGY(2010)引用 1|浏览6暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要